Homepage033780 • KRX
add
KT&G Corp
Vorige slotkoers
â‚©Â 143.700,00
Dag-range
â‚©Â 142.100,00 - â‚©Â 143.900,00
Jaar-range
â‚©Â 94.600,00 - â‚©Â 150.500,00
Beurswaarde
16,79Â bln. KRW
Gem. volume
255,02K
Koers/winst
11,91
Dividendrendement
3,94%
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (KRW) | sep 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 1,83Â bln. | 11,64% |
Bedrijfskosten | 428,60Â mld. | -0,72% |
Netto inkomsten | 419,25Â mld. | 73,79% |
Netto winstmarge | 22,95 | 55,70% |
Winst per aandeel | 3,87K | 70,82% |
EBITDA | 540,52Â mld. | 12,60% |
Effectief belastingtarief | 23,62% | — |
Balans
Totale activa
Totale passiva
| (KRW) | sep 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 1,74Â bln. | -11,04% |
Totale activa | 14,78Â bln. | 9,61% |
Totale passiva | 5,61Â bln. | 32,02% |
Totaal aandelenvermogen | 9,17 bln. | — |
Uitstaande aandelen | 103,79 mln. | — |
Koers-boekwaardeverhouding | 1,66 | — |
Rendement op activa | 8,07% | — |
Rendement op kapitaal | 10,34% | — |
Kasstroom
Nettomutatie in liquide middelen
| (KRW) | sep 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 419,25Â mld. | 73,79% |
Operationele kasstroom | 275,83Â mld. | -23,69% |
Kasstroom uit beleggingen | -100,30Â mld. | -323,37% |
Kasstroom uit financiering | -180,76Â mld. | -20,73% |
Nettomutatie in liquide middelen | 13,56Â mld. | -93,07% |
Vrije kasstroom | -11,46Â mld. | -102,33% |
Over
KT&G Corporation, originally Korea Tobacco & Ginseng, also branded as Korea Tomorrow & Global, is the leading tobacco company in South Korea with annual sales over US$4 billion. KT&G was originally a government-owned monopoly but was privatised and today is publicly traded, competing for market share with other international tobacco firms such as Philip Morris International, British American Tobacco, and Japan Tobacco. KT&G's sales volume share was 62% of the Korean market in 2009.
KT&G also owns significant subsidiaries such as Korea Ginseng Corporation, Yungjin Pharm, and several bio ventures. Its headquarters are in Daejeon. Wikipedia
Opgericht
1 apr 1987
Hoofdvestiging
Website
Werknemers
4.402